JiangXi Tianxin Pharm Co Ltd (603235) — Cash Flow Reinvestment Rate
JiangXi Tianxin Pharm Co Ltd (603235) has a Cash Flow Reinvestment Rate of 0.92x as of December 2025, reinvesting CN¥580.68 Million (capex CN¥580.68 Million ) from operating cash flow of CN¥629.36 Million. See 603235 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
JiangXi Tianxin Pharm Co Ltd Cash Flow Reinvestment Rate (2020–2025)
Historical reinvestment intensity for JiangXi Tianxin Pharm Co Ltd across 6 annual periods. For the full cash flow conversion analysis, see JiangXi Tianxin Pharm Co Ltd (603235) cash conversion ratio.
Annual Cash Flow Reinvestment Rate for JiangXi Tianxin Pharm Co Ltd (2020–2025)
Year-by-year capital reinvestment analysis for JiangXi Tianxin Pharm Co Ltd. See how financially flexible is JiangXi Tianxin Pharm Co Ltd to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.92x | CN¥580.68 Million | CN¥629.36 Million | CN¥580.68 Million | ▼ -82.3% |
| 2024 | 5.22x | CN¥2.61 Billion | CN¥499.66 Million | CN¥1.07 Billion | ▲ +353.7% |
| 2023 | 1.15x | CN¥838.75 Million | CN¥729.21 Million | CN¥535.60 Million | ▼ -2.5% |
| 2022 | 1.18x | CN¥715.84 Million | CN¥606.61 Million | CN¥260.50 Million | ▲ +112.3% |
| 2021 | 0.56x | CN¥455.04 Million | CN¥818.63 Million | CN¥215.50 Million | ▲ +7.7% |
| 2020 | 0.52x | CN¥600.51 Million | CN¥1.16 Billion | CN¥303.04 Million | — |